J. Goldman & CO LP Gamida Cell Ltd. Transaction History

J. Goldman & CO LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$5.85 - $8.33 $865,659 - $1.23 Million	-147,976 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$7.8 - $12.43 $1.3 Million - $2.07 Million	-166,260 Reduced 52.91%	147,976 $1.2 Million
Q4 2020 Feb 16, 2021	BUY	$4.07 - $11.0 $1.28 Million - $3.46 Million	314,236 New	314,236 $2.64 Million

2.2K

Ticker GMDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,319,600
Market Cap $2.29M
Description
Gamida Cell Ltd., a clinical-stage biopharmaceutical company, develops cell therapies to cure blood cancers and serious hematologic diseases. The company's lead product candidate is omidubicel, a cell therapy that has completed Phase III clinical trial in patients with high-risk hematologic malignancies, as well as in Phase I/II clinical trials ...

Get notified when there are updates to the investment portfolio of J. Goldman & CO LP, based on Form 13F filings with the SEC.

Stay updated on J. Goldman & CO LP with notifications on news.